business
Morgan Stanley drops one big takeaway in CVS stock earnings beat
Key takeaways
- Morgan Stanley drops one big takeaway in CVS stock earnings beat Mwangi Enos Mon, May 11, 2026 at 12:47 AM GMT+7 5 min read MS CVS Healthcare stocks have had a rough stretch.
- Walking into a CVS Health earnings report in that environment felt like bracing for bad news.
- CVS Health (CVS) posted first-quarter 2026 adjusted EPS of $2.57, according to its earnings report, blowing past both Morgan Stanley's $2.17 estimate and the $2.18 consensus by 40 cents.
Morgan Stanley drops one big takeaway in CVS stock earnings beat Mwangi Enos Mon, May 11, 2026 at 12:47 AM GMT+7 5 min read MS CVS Healthcare stocks have had a rough stretch. Rising medical costs, Medicaid pressure, and persistent skepticism about managed care margins have kept investors on edge all year.
Walking into a CVS Health earnings report in that environment felt like bracing for bad news. The bad news, however, didn't come.
CVS Health (CVS) posted first-quarter 2026 adjusted EPS of $2.57, according to its earnings report, blowing past both Morgan Stanley's $2.17 estimate and the $2.18 consensus by 40 cents.
Article preview — originally published by Yahoo Finance. Full story at the source.
Read full story on Yahoo Finance →
More top stories
Also covered by
Investing.com
Earnings call transcript: Palantir Q1 2026 earnings beat, stock drops
Investing.com
Earnings call transcript: Backblaze Q1 2026 earnings beat boosts stock
Investing.com
Earnings call transcript: Geberit Q1 2026 sees revenue beat, stock dips
Investing.com
Earnings call transcript: Aviat Networks Q3 2026 misses EPS forecast, stock drops
Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop